Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person15
BioKey (Cayman), Inc.
Company
CooTek(Cayman)Inc.
Company
Troops, Inc. /Cayman Islands/
Company
Climb Bio, Inc.
Company
BiomX Inc.
Company
BIOXYTRAN, INC
Company
Cabaletta Bio, Inc.
Company
Canaan Inc.
Company
BIOVIE INC.
Company
BIOGEN INC.
Company
BioAtla, Inc.
Company
Q32 Bio Inc.
Company
GRI Bio, Inc.
Company
Intercont (Cayman) Ltd
Company
CAE INC
Company
Primary record6
ABVC BIOPHARMA, INC. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement On August 21, 2026, ABVC BioPharma, Inc. (the Company ) completed the previously announced partial legal and structural separation (the Reorganization Transactions ) o
BioKey (Cayman), Inc. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement BioKey (Cayman), Inc., an exempted company incorporated with limited liability under the laws of the Cayman Islands (the Company ), previously filed with the U.S. Secu
BioKey (Cayman), Inc. filed NT 10-Q
WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (CHECK ONE): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-SAR For Period Ended: June 30, 2026 ☐ Transition Report on Form 10-K ☐ Transition Repor
BioKey (Cayman), Inc. filed 8-K
Item 4.01 Changes in Registrant s Certifying Accountant. On August 1, 2026, the audit committee of the board of directors of BioKey (Cayman), Inc. (the Corporation ) approved the dismissal of Simon & Edward, LLP ( S&E )
BioKey (Cayman), Inc. filed 8-K
Item 8.01 Other Events. On August 3, 2026, ABVC BioPharma, Inc. (“ ABVC ”), which was the parent company of BioKey (Cayman), Inc. (the “ Company ”) prior to the separation of the Company from ABVC
ABVC BIOPHARMA, INC. filed 8-K
Item 8.01 Other Events. On August 3, 2026, ABVC BioPharma, Inc. (the Company ) determined to postpone the previously announced distribution of ordinary shares of BioKey (Cayman), Inc. (the Distribution ), which had been